The liver cancer treatment that’s right for you depends mainly on how much of the liver is affected by cancer, its stage, and your overall health. You and your oncologist work together to create a treatment plan that meets your needs.
Early-stage liver cancer is usually treated with the intent to cure the patient. Treatment for late-stage liver cancer may not be able to cure the disease but will help the patient live a higher quality of life by slowing the cancer growth and managing symptoms.
Surgery is the most effective way to treat liver cancer. By removing the cancerous cells, the liver can regenerate healthy cells.
Compass Oncology’s liver cancer treatment team includes a hepatobiliary surgeon, who works with the medical and radiation oncologists to determine the right timing of surgery and whether other treatments should be given first.
Ablation is a way of destroying cancer cells without surgically removing them. It’s best for smaller tumors, less than 3 centimeters, and may be used as a treatment option while a patient is waiting for a liver transplant.
The Compass Oncology team will typically perform a radiofrequency ablation if this treatment is needed. However, there are several ways an ablation can be performed, including:
Embolization is a procedure typically for patients who can't have surgery or a liver transplant. It may also be combined with ablation for some larger tumors.
During embolization, substances are injected into the body to reduce or block the blood flow to cancer cells. Blocking the blood flow from the hepatic artery causes the tumor to die. Even though the hepatic artery is blocked, healthy liver tissue can still receive blood flowing from the hepatic portal vein.
There are two main types of embolization therapy:
Radiation therapy uses high doses of radiation to kill cancer cells. This type of treatment is often best for patients who can’t have surgery or to help relieve pain from liver cancer that has spread to the bones. Radiation therapy may be combined with other liver cancer treatments and given in a few different ways:
Patients who can't have surgery or a liver transplant may receive targeted therapy. The most common type of targeted therapy for liver cancer is a category of drugs called kinase inhibitors. Proteins called kinases are found on the surface of cells and tell the cell how to function. Some kinases help liver cancer grow, while others help form new blood supplies to the tumor so it can grow. In either of these situations, kinase inhibitor drugs will stop these signals and stop the cancer’s growth.
Another type of targeted therapy found effective for liver cancer is an angiogenesis inhibitor. Lab-made monoclonal antibodies are given to the patient to block the tumor's ability to form new blood vessels. This will essentially starve the cancer of the fuel it needs to grow.
Fatigue, loss of appetite, mouth sores, headaches, high blood pressure, weight loss, diarrhea, pain in the abdomen, and hand-foot syndrome (redness and irritation of the hands and feet) are common side effects associated with various targeted therapy drugs.
Immunotherapy stimulates the body's immune system to fight cancer. Cells have a “checkpoint” that allows the body to see them as healthy or damaged, allowing the body to destroy unhealthy cells. Cancer cells will turn off the checkpoint so the body thinks the cells are healthy. Checkpoint inhibitor drugs can force the body to see cancer cells as something to be attacked.
Fever, cough, skin rash, nausea, loss of appetite, muscular or joint pain, and fatigue are common side effects of immunotherapy treatment.
Chemotherapy is not widely used as a first-line treatment for liver cancer because it’s not as effective as other treatments. Research has proven that a combination of drugs is the most effective when chemotherapy is used. The most common combination is GEMOX, which combines gemcitabine and oxaliplatin. FOLFOX is another option combining 5-FU, oxaliplatin, and leucovorin.
Common side effects of chemotherapy include fatigue, hair loss, nausea, vomiting, loss of appetite, mouth sores, easy bruising, and increased likelihood of infections. Those who receive FOLFOX have a high sensitivity to heat and cold, especially in the hands and feet.
Some liver cancer patients might be eligible to take part in a clinical trial. Clinical trials study new treatments that could improve or replace standard cancer treatments. Some treatments tested during clinical trials could benefit certain liver cancer patients. However, it’s important to understand that clinical trial participation may have a higher risk as there are more unknowns.
Compass Oncology offers clinical trials for qualifying liver cancer patients. Speak to your oncologist about the available trials and your eligibility.
If you have been newly diagnosed with liver cancer, the first step is to schedule a consultation with an oncologist who specializes in liver cancer. If you are in the Portland, OR, or Vancouver, WA area, we use a multidisciplinary approach that includes a liver cancer surgeon. We offer personalized treatment plans and second opinions on treatment.
Find a location convenient to you and schedule a consultation with a liver oncologist about your specific diagnosis and treatment plans.